CERS
Price
$1.53
Change
-$0.05 (-3.16%)
Updated
Oct 17 closing price
Capitalization
293.3M
12 days until earnings call
QTRX
Price
$5.86
Change
-$0.09 (-1.51%)
Updated
Oct 17 closing price
Capitalization
272.29M
18 days until earnings call
Interact to see
Advertisement

CERS vs QTRX

Header iconCERS vs QTRX Comparison
Open Charts CERS vs QTRXBanner chart's image
Cerus
Price$1.53
Change-$0.05 (-3.16%)
Volume$1.36M
Capitalization293.3M
Quanterix
Price$5.86
Change-$0.09 (-1.51%)
Volume$373.08K
Capitalization272.29M
CERS vs QTRX Comparison Chart in %
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. QTRX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and QTRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (CERS: $1.53 vs. QTRX: $5.86)
Brand notoriety: CERS and QTRX are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CERS: 96% vs. QTRX: 64%
Market capitalization -- CERS: $293.3M vs. QTRX: $272.29M
CERS [@Medical/Nursing Services] is valued at $293.3M. QTRX’s [@Medical/Nursing Services] market capitalization is $272.29M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $223.72B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, CERS is a better buy in the long-term than QTRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while QTRX’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 6 bearish.
  • QTRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CERS and QTRX are a bad buy in the short-term.

Price Growth

CERS (@Medical/Nursing Services) experienced а -4.38% price change this week, while QTRX (@Medical/Nursing Services) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.22%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +18.56%.

Reported Earning Dates

CERS is expected to report earnings on Nov 06, 2025.

QTRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($293M) has a higher market cap than QTRX($272M). CERS YTD gains are higher at: -0.649 vs. QTRX (-44.873). CERS has higher annual earnings (EBITDA): -8.62M vs. QTRX (-72.89M). QTRX has more cash in the bank: 261M vs. CERS (78M). QTRX has less debt than CERS: QTRX (35.5M) vs CERS (98.9M). CERS has higher revenues than QTRX: CERS (193M) vs QTRX (124M).
CERSQTRXCERS / QTRX
Capitalization293M272M108%
EBITDA-8.62M-72.89M12%
Gain YTD-0.649-44.8731%
P/E RatioN/AN/A-
Revenue193M124M156%
Total Cash78M261M30%
Total Debt98.9M35.5M279%
FUNDAMENTALS RATINGS
CERS vs QTRX: Fundamental Ratings
CERS
QTRX
OUTLOOK RATING
1..100
7361
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9691
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (32) in the Pharmaceuticals Major industry is in the same range as CERS (40) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to CERS’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CERS (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to CERS’s over the last 12 months.

QTRX's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as CERS (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to CERS’s over the last 12 months.

QTRX's Price Growth Rating (91) in the Pharmaceuticals Major industry is in the same range as CERS (96) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to CERS’s over the last 12 months.

QTRX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CERS (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSQTRX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CODGF105.00N/A
N/A
Compagnie de Saint-Gobain
CMOPF83.05N/A
N/A
Cosmo Pharmaceuticals NV
FKYS16.90-0.15
-0.88%
First Keystone Corp.
PREIF0.08N/A
-4.25%
Precipitate Gold Corp
FCODF1535.00-75.00
-4.66%
COMPAGNIE DE L ODET

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ITGR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-3.16%
ITGR - CERS
53%
Loosely correlated
+1.66%
LAB - CERS
47%
Loosely correlated
-1.55%
ICUI - CERS
46%
Loosely correlated
+1.69%
UTMD - CERS
45%
Loosely correlated
-1.07%
BLFS - CERS
45%
Loosely correlated
-1.48%
More

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with TWST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
-1.51%
TWST - QTRX
49%
Loosely correlated
-8.42%
ILMN - QTRX
49%
Loosely correlated
-0.47%
RVTY - QTRX
45%
Loosely correlated
-0.54%
BRKR - QTRX
44%
Loosely correlated
-3.19%
CERS - QTRX
44%
Loosely correlated
-3.16%
More